Literature DB >> 1842175

Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma.

J W Smith1, M H Shiu, L Kelsey, M F Brennan.   

Abstract

Recent studies suggest an improved survival in patients who undergo radical lymph node dissection for the curative treatment of gastric carcinoma. We have undertaken a retrospective review to compare morbidity and mortality between patients who underwent radical lymph node dissection and those who underwent resections of lesser scope. Of the surgically related events compared, only the amount of postoperative abdominal drainage was significantly different in the group that underwent radical lymph node dissection Forty-four percent of patients who underwent radical lymph node dissection and 35% of patients who underwent a procedure of lesser scope developed a major complication. There was also no significant difference in the postoperative death rate, with a total of two 30-day in-hospital deaths (1.1%). Our observations indicate that radical lymph node dissection can be performed as safely as lesser operations for gastric carcinoma, and should not be avoided because of the fear of complications.

Entities:  

Mesh:

Year:  1991        PMID: 1842175     DOI: 10.1001/archsurg.1991.01410360039007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  29 in total

1.  Relevant prognostic factors in gastric cancer.

Authors:  D H Roukos
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

2.  Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma.

Authors:  R C G Martin; G C Vitale; D N Reed; G M Larson; M J Edwards; K M McMasters
Journal:  Surg Endosc       Date:  2002-01-09       Impact factor: 4.584

3.  Complications following D3 gastrectomy: post hoc analysis of a randomized trial.

Authors:  Chew-Wun Wu; I-Shou Chang; Su-shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

4.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

5.  A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

Authors:  D Roukos; G Marcouizos; C Batsis; A Kappas; A Encke
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

6.  Morbidity after Total Gastrectomy: Analysis of 238 Patients.

Authors:  Luke V Selby; Emily A Vertosick; Daniel D Sjoberg; Mark A Schattner; Yelena Y Janjigian; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  J Am Coll Surg       Date:  2015-02-16       Impact factor: 6.113

7.  Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution.

Authors:  Shouji Shimoyama; Yasuyuki Seto; Hidemitsu Yasuda; Ken-ichi Mafune; Michio Kaminishi
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

8.  Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience.

Authors:  Alberto Di Leo; Daniele Marrelli; Franco Roviello; Marco Bernini; AnnaMaria Minicozzi; Simone Giacopuzzi; Corrado Pedrazzani; Luca Gian Baiocchi; Giovanni de Manzoni
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

9.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer.

Authors:  Min-Chan Kim; Hyung-Ho Kim; Ghap-Joong Jung; Jong-Hun Lee; Seok-Ryeol Choi; Do-Young Kang; Mee-Sook Roh; Jin-Sook Jeong
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.